Letter to the editor: Absence of cross-reactivity of the cobas WNV assay with human pegiviruses

References

1. Orru’ S, Reissinger A, Filomena A, Heitmann A, Funk MB, Schmidt-Chanasit J, et al. Assessment of the effectiveness of West Nile virus screening by analysing suspected positive donations among blood donors, Germany, 2020 to 2023. Euro Surveill. 2025;30(8):2400373.  https://doi.org/10.2807/1560-7917.ES.2025.30.8.2400373  PMID: 40017391 
2. Stanley J, AuBuchon JP, Erickson Y, Waxman DA, Williamson PC, Bertuzis R, et al. Evaluation of a new West Nile virus nucleic acid test for screening of blood donations. Transfusion. 2019;59(2):623-8.  https://doi.org/10.1111/trf.15022  PMID: 30427542 
3. Silva ASN, Silva CP, Barata RR, da Silva PVR, Monteiro PDJ, Lamarão L, et al. Human pegivirus (HPgV, GBV-C) RNA in volunteer blood donors from a public hemotherapy service in Northern Brazil. Virol J. 2020;17(1):153.  https://doi.org/10.1186/s12985-020-01427-6  PMID: 33054824 
4. Yang N, Dai R, Zhang X. Global prevalence of human pegivirus-1 in healthy volunteer blood donors: a systematic review and meta-analysis. Vox Sang. 2020;115(3):107-19.  https://doi.org/10.1111/vox.12876  PMID: 31845353